Barriers to healthcare and their relationship to well-being and social support for autistic adults during COVID-19.
COVID-19
access to healthcare
autism
autistic adults
emotional well-being
health services delivery
Journal
Primary health care research & development
ISSN: 1477-1128
Titre abrégé: Prim Health Care Res Dev
Pays: England
ID NLM: 100897390
Informations de publication
Date de publication:
14 12 2022
14 12 2022
Historique:
entrez:
14
12
2022
pubmed:
15
12
2022
medline:
16
12
2022
Statut:
epublish
Résumé
The present study aimed to investigate barriers to healthcare and their relationships to social and emotional well-being and intersectional inequalities for autistic adults during COVID-19 restrictions in the UK. Autistic adults experience severe health inequalities and report more barriers to accessing health services compared to other both disabled and non-disabled populations. The COVID-19 pandemic has impacted many areas of society that may have increased vulnerability of autistic people to social and health inequalities, including delivery of healthcare from in-person to remote methods. One hundred twenty-eight autistic adults who lived in the UK took part in an online survey. Measures included the Barriers to Healthcare Checklist (Short Form) and PROMIS outcome measure bank to assess emotional well-being and social support. Participants rated their agreement with items, retrospectively considering three different points of the trajectory of COVID-19 restrictions: before COVID-19, during the first lockdown in spring 2020, and in the month prior to taking the survey during autumn 2020. They completed a follow-up survey six months later to continue to assess change as restrictions in the UK were eased. The average number of barriers to healthcare showed no significant change between all four time points. However, the nature of barriers to healthcare changed at the point of lockdown and persisted beyond the easing of COVID-19 restrictions. Barriers to healthcare were associated with some social and emotional well-being variables and demographic groups including gender, education and presence of additional disabilities. The findings may help to identify areas to target to improve access to both remote and in-person health systems for autistic people as modes of delivery continue to change over time.
Sections du résumé
AIM
The present study aimed to investigate barriers to healthcare and their relationships to social and emotional well-being and intersectional inequalities for autistic adults during COVID-19 restrictions in the UK.
BACKGROUND
Autistic adults experience severe health inequalities and report more barriers to accessing health services compared to other both disabled and non-disabled populations. The COVID-19 pandemic has impacted many areas of society that may have increased vulnerability of autistic people to social and health inequalities, including delivery of healthcare from in-person to remote methods.
METHOD
One hundred twenty-eight autistic adults who lived in the UK took part in an online survey. Measures included the Barriers to Healthcare Checklist (Short Form) and PROMIS outcome measure bank to assess emotional well-being and social support. Participants rated their agreement with items, retrospectively considering three different points of the trajectory of COVID-19 restrictions: before COVID-19, during the first lockdown in spring 2020, and in the month prior to taking the survey during autumn 2020. They completed a follow-up survey six months later to continue to assess change as restrictions in the UK were eased.
FINDINGS
The average number of barriers to healthcare showed no significant change between all four time points. However, the nature of barriers to healthcare changed at the point of lockdown and persisted beyond the easing of COVID-19 restrictions. Barriers to healthcare were associated with some social and emotional well-being variables and demographic groups including gender, education and presence of additional disabilities. The findings may help to identify areas to target to improve access to both remote and in-person health systems for autistic people as modes of delivery continue to change over time.
Identifiants
pubmed: 36515013
pii: S1463423622000755
doi: 10.1017/S1463423622000755
pmc: PMC9817085
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e79Subventions
Organisme : Department of Health
Pays : United Kingdom
Références
Autism. 2022 Oct;26(7):1765-1782
pubmed: 35083922
BMJ Open. 2022 Feb 22;12(2):e056904
pubmed: 35193921
Autism Res. 2021 Sep;14(9):1896-1904
pubmed: 34213066
Lancet Psychiatry. 2015 Nov;2(11):1013-27
pubmed: 26544750
Autism. 2021 Feb;25(2):389-404
pubmed: 33023296
Autism. 2021 Apr;25(3):774-785
pubmed: 33910390
Autism Res. 2020 Jun;13(6):970-987
pubmed: 32154664
Lancet. 2020 Apr 11;395(10231):1180-1181
pubmed: 32278374
J Clin Epidemiol. 2010 Nov;63(11):1179-94
pubmed: 20685078
BMJ. 2020 Nov 23;371:m4493
pubmed: 33229395
Mol Psychiatry. 2018 Feb;23(2):257-262
pubmed: 28242872
J Am Acad Child Adolesc Psychiatry. 2012 Feb;51(2):202-212.e7
pubmed: 22265366
Autism Res. 2021 Dec;14(12):2663-2676
pubmed: 34545706
BMJ Open. 2021 Mar 16;11(3):e045343
pubmed: 33727273
BJGP Open. 2022 Mar 22;6(1):
pubmed: 35074849
Qual Life Res. 2017 Nov;26(11):2973-2985
pubmed: 28681335
J Autism Dev Disord. 2020 Aug;50(8):3071-3077
pubmed: 32056117
J Autism Dev Disord. 2022 Aug;52(8):3639-3654
pubmed: 34482523
Arch Gen Psychiatry. 2011 May;68(5):459-65
pubmed: 21536975
Autism. 2017 Nov;21(8):972-984
pubmed: 27663266
Res Dev Disabil. 2021 Oct;117:104057
pubmed: 34371305
Dev Med Child Neurol. 2012 Apr;54(4):306-12
pubmed: 22348343
Autism. 2018 Nov;22(8):970-982
pubmed: 28914080
Br J Psychiatry. 2016 Mar;208(3):232-8
pubmed: 26541693
J Autism Dev Disord. 2019 Aug;49(8):3387-3400
pubmed: 31124030
Med Care. 2007 May;45(5 Suppl 1):S3-S11
pubmed: 17443116
Autism. 2015 Oct;19(7):814-23
pubmed: 25911091
Autism Adulthood. 2020 Jun 1;2(2):106-117
pubmed: 36601566
Autism Res. 2021 Jun;14(6):1209-1219
pubmed: 33559334
BMJ. 2022 Apr 13;377:o491
pubmed: 35418498